Nishio H

ORCID: 0009-0004-7428-0532 · 6 papers in corpus
diagnostic-accuracy 2026
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics16203387

Background/Objectives: Cervical cancer (CC) is usually caused by high-risk human papillomavirus (hrHPV); however, some hrHPV-negative cases are undetectable by current screening programs. We evaluated a previously established diagnostic mod…

observational 2025
Journal of neuroscience methods ·doi:10.1016/j.jneumeth.2025.110430

BACKGROUND: Gamma-aminobutyric acid (GABA) and glutathione (GSH) play a significant role in the functioning of a healthy brain and can both be quantified using magnetic resonance spectroscopy (MRS). Several small-scale studies have suggeste…

observational 2025
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_144_23

OBJECTIVES: The initial learning curve is a barrier to introducing robotic surgery. Evidence regarding appropriate simulation programs that allow for a smooth introduction of gynecological robotic surgery remains limited. MATERIALS AND MET…

diagnostic-accuracy 2024
Scientific reports ·doi:10.1038/s41598-024-71606-w

Despite widespread cervical cancer (CC) screening programs, low participation has led to high morbidity and mortality rates, especially in developing countries. Because early-stage CC often has no symptoms, a non-invasive and convenient dia…

diagnostic-accuracy 2023
Cancer research communications ·doi:10.1158/2767-9764.crc-23-0138

UNLABELLED: Ovarian cancer has a poor prognosis and is difficult to detect in early stages. Therefore, developing new diagnostic markers for early-stage ovarian cancer is critical. Here, we developed a diagnostic marker for early-stage ovar…

2004
The Malaysian journal of medical sciences : MJMS

Optical technologies using laser spectroscopy and imaging offer the ability to non-invasively diagnose and monitor early cancers in-vivo. For many precancers and early cancers the current standard of care relies on histopathological assessm…